ActivSight Intelligent Light attaches to laparoscopic systems to provide real-time, on-demand surgical insights. Credit: Activ Surgical / Business Wire.

Activ Surgical has announced receipt of CE Mark approval for its enhanced imaging system, ActivSight Intelligent Light.

The approval of the easy-to-adapt module validates that it meets the requirements of the European Medical Devices Regulation.

Related Company Profiles

View all

Activ Surgical will now be able to commercialise ActivSight across the European Union and other regions where the CE Mark is required.

Designed to be a routine part of surgical practice, ActivSight attaches to existing laparoscopic systems and provides on-demand, real-time surgical insights.

It is said to be the first and only modular form factor with multimodal advanced visualisation for surgeries that are minimally invasive.

A hardware-agnostic module, ActivSight provides surgeons with critical intraoperative visual data and imaging to help improve patient safety and outcomes in the operating room.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Activ Surgical CEO Todd Usen said: “The team at Activ Surgical is thrilled to achieve the CE Mark for ActivSight in the European Union and beyond.

“This clearance represents a momentous step forward for the company as we execute against our global commercialisation strategy for the system.

“We believe ActivSight will be a game-changer in the operating room by revolutionising surgical vision and, ultimately, improving surgical care and patient safety.”

Using ActivSight, surgeons can augment their senses with the help of reality overlays.

Last year, the US Food and Drug Administration (FDA) granted 510(k) clearance for ActivSight, which has already seen clinical use in more than 200 patients and multiple in-human institutional review board (IRB) trials successfully.

Currently, several major US and European hospital networks have been established as pilot sites for the system.